Reality and Legality: Disentangling What Is Actual from What Is Tolerated in Comparisons of Hemp Extracts with Pure CBD.

Journal of Dietary Supplements
P S Cogan

Abstract

Manufacturers of hemp-based cannabidiol products have argued that their products should be federally regulated as dietary supplements in the U.S. The justifications offered for this suggestion often focus on a variety of assumptions that either are commonly invoked in marketing strategies of the cannabis/hemp industry or are codified in the 1994 Dietary Supplement Health Education Act. Three such assumptions are addressed herein and are characterized as: 1) the false dichotomy of herbs vs drugs, 2) the entourage fallacy, and 3) the false equivalence of incomparable evidence. An argument is presented which is intended to persuade that the legality or mere composition of phytochemical products do not speak to the reality of their pharmacological effects. It is further argued that non-prescription cannabidiol and hemp extracts should not be afforded regulatory protection by designation as dietary supplements.

References

Jan 1, 1995·Food and Drug Law Journal·A L Young, I S Bass
Jan 9, 2001·Controlled Clinical Trials·M A Proschan, M A Waclawiw
Feb 13, 2001·BMJ : British Medical Journal·J A Sterne, G Davey Smith
Jul 7, 2001·BMJ : British Medical Journal·P JüniM Egger
Jan 22, 2004·Lancet·Roxanne Nelson
Nov 13, 2004·Annals of Internal Medicine·Edgar R MillerEliseo Guallar
Dec 8, 2004·Lancet·Peter JüniMatthias Egger
Aug 3, 2005·PLoS Medicine·John P A Ioannidis
Sep 9, 2005·American Journal of Law & Medicine·Peter J Cohen
Jun 19, 2007·Pharmacology & Therapeutics·Mark D Lindner
Aug 19, 2007·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·K P MishraR C Sawhney
Feb 27, 2008·Archives of Internal Medicine·Joachim BleysEliseo Guallar
Aug 30, 2008·JAMA : the Journal of the American Medical Association·Bruce M Psaty, Jan P Vandenbroucke
May 17, 2011·Pharmacoepidemiology and Drug Safety·Zaina P QureshiSheryl L Szeinbach
Jul 14, 2011·British Journal of Pharmacology·Ethan B Russo
Aug 2, 2011·Expert Opinion on Drug Safety·Herbert M van WeringMarc A Benninga
Apr 27, 2012·Journal of the National Cancer Institute·María Elena MartínezTim Byers
Apr 11, 2013·Nature Reviews. Neuroscience·Katherine S ButtonMarcus R Munafò
Jul 31, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Abhishek GoyalAbby B Siegel
Nov 19, 2013·Current Opinion in Clinical Nutrition and Metabolic Care·Goran BjelakovicChristian Gluud
Apr 20, 2014·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Esther K ChooK John McConnell
Dec 1, 2004·Drug Discovery Today. Technologies·Christopher A Lipinski
Oct 22, 2014·JAMA : the Journal of the American Medical Association·Pieter A CohenJames Neal-Kababick
Jan 21, 2015·American Journal of Public Health·Ranjani R Starr
Mar 2, 2016·Journal of Health Economics·Joseph A DiMasiRonald W Hansen
Nov 5, 2016·Nature Reviews. Drug Discovery·Richard K Harrison
Dec 17, 2016·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·E L AndradeJ B Calixto
Jan 25, 2017·Preventive Medicine·Rosemary J AveryJonathan H Cantor
Feb 14, 2017·Journal of Pharmacological and Toxicological Methods·Brian D Guth, Michael K Pugsley
Feb 3, 2018·Biostatistics·Chi Heem WongAndrew W Lo
Jul 17, 2018·Pediatric Neurology Briefs·Daniel A Freedman, Anup D Patel
Oct 20, 2018·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Tjaša Ekar, Samo Kreft
Dec 5, 2018·Journal of the American College of Nutrition·Taylor C WallaceLinda T Vahdat
Feb 7, 2019·Internet Interventions : the Application of Information Technology in Mental and Behavioural Health·Victoria A M OwensBlake F Dear
Jun 5, 2019·Current Neuropharmacology·Marilyn A HuestisFrancesco Paolo Busardò
Jun 13, 2019·The Journal of the Royal College of Physicians of Edinburgh·Joanne LuaChris Isles
Jun 22, 2019·British Journal of Clinical Pharmacology·S A MillarS E O'Sullivan
Nov 7, 2019·Journal of the American College of Nutrition·Arne Astrup, Okezie I Aruoma

❮ Previous
Next ❯

Citations

Jul 28, 2020·Journal of Dietary Supplements·Igor Koturbash, Douglas MacKay
Feb 23, 2021·Frontiers in Pharmacology·Cássio Morais LossVanessa Costhek Abílio

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.